
EARLY RELEASE: Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022
Published on July 15, 2022
This report describes the effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among adults
